Tateiwa Toshiyuki, Takahashi Yasuhito, Ishida Tsunehito, Kubo Kosuke, Masaoka Toshinori, Shishido Takaaki, Sano Keiji, Yamamoto Kengo
Department of Orthopedic Surgery, Tokyo Medical University, Tokyo, Japan.
Department of Orthopedic Surgery, Tokyo Medical University, Tokyo, Japan ; Department of Bone and Joint Biomaterial Research, Tokyo Medical University, Tokyo, Japan.
Ther Clin Risk Manag. 2015 Sep 15;11:1383-9. doi: 10.2147/TCRM.S89816. eCollection 2015.
It has been recognized that perioperative hemostasis management after joint-replacement surgery for hemophilia patients is complicated and cumbersome, due to the necessity of rigorous monitoring for clotting-factor levels throughout the infusion. Between 2005 and 2014, we examined seven patients with hemophilia A (ten joints: six hips and four knees) receiving total hip or knee arthroplasty (THA or TKA) for hemophilic arthropathy. One male patient (31 years old) showed an intra-articular hematoma formation after THA (case 1). In another male patient (46 years old) receiving TKA, the postoperative trough factor VIII level became lower significantly than reference levels (80%-100% for the 5-10 postoperative days) recommended by the guidelines from the Japanese Society on Thrombosis and Hemostasis, despite sufficient coagulant based on the guidelines being administered (case 2). In the latter patient, deep infection and hematoma formation were observed postoperatively. In this article, we provide a detailed clinical report regarding these two complication cases at the early postoperative periods, and the management of bleeding control for hemophilia patients is discussed.
人们已经认识到,血友病患者关节置换手术后的围手术期止血管理复杂且繁琐,因为在整个输注过程中需要严格监测凝血因子水平。2005年至2014年期间,我们检查了7例甲型血友病患者(10个关节:6个髋关节和4个膝关节),他们因血友病性关节病接受了全髋关节或膝关节置换术(THA或TKA)。1例男性患者(31岁)在THA后出现关节内血肿形成(病例1)。在另1例接受TKA的男性患者(46岁)中,尽管按照日本血栓与止血学会指南给予了足够的凝血剂,但术后最低因子VIII水平仍显著低于该指南推荐的参考水平(术后5 - 10天为80% - 100%)(病例2)。在该患者中,术后观察到深部感染和血肿形成。在本文中,我们提供了关于这两例术后早期并发症病例的详细临床报告,并讨论了血友病患者出血控制的管理。